Zhao Qigang, Jia Xiuqin, Pang Feng, Li Yanhua
Department of Clinical Laboratory, Liaocheng People's Hospital, Liaocheng 252000, China.
Email:
Zhonghua Yi Xue Za Zhi. 2015 Oct;95(40):3264-8.
To study the genotypes and clinical characteristics of carbapenemase-producing Enterobacter cloacae (E.cloacae), and lay the foundation for active control of nosocomial infection.
E.cloacae isolates were collected from January 2007 to December 2014. Strains which showed decreased sensitivity to carbapenem were screened out by the modified Hodge test (MHT) and EDTA-disk synergy test. The genotype of blaKPC, blaIMP, blaVIM, blaOXA-48 and blaNDM-1 were detected by PCR amplication, the product of PCR was sequenced and conducted by Blast (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Conjugal transfer experiment was conducted to prove horizontal transmit of carbapenemase gene produced by E.cloacae. Meanwhile, the clinical epidemiological data of patients infected by selected strains were also analyzed.
Sixty-four carbapenemase producing E.cloacae were detected by MHT, EDTA-disk synergy test and PCR amplification. Forty-five strains (70.3%) out of 64 strains infection came from nosocomial infection, while 19 strains (29.7%) from the community infection. The strains were mainly isolated from secretions samples and sputum samples, which accounted for 65.6% (42/64) and 23.4% (15/64) separately. The mainly clinical departments were orthopaedics (43.8%), department of burn (21.9%), ICU (18.8%) and pediatrics (14.1%). Bed changing, invasive operation and indwelling catheter were risk factors for the transmission of carbapenemase producing E.cloacae, and infected patients had longer time of staying in hospital, lower cure rate and higher frequency of cephalosporins enzyme inhibitor compound or carbapenem agents administration (all P<0.05). Sixty-four strains showed increased MIC to most of the antibiotics except for polymyxin and tigecycline. Among the 64 strains, 29 strains were genotype blaIMP-4 and 35 strains were genotype blaIMP-8 by Blast alignment, no genotype blaVIM, blaOXA-48 and blaNDM-1 were detected. Result of conjugal transfer experiment showed that receptor strain obtained carbapenem resistance, and the sequence of resistance gene of receptor strain was the same to the donator strain.
The drug resistance of E.cloacae are growing, IMP-4 and IMP-8 carbapenemase are the main enzymes produced by strains. As the resistance gene can horizontal transmit between strains through conjugal transfer system, the strains have been locally spread in hospital departments, thus it is important to control risk factors of transmission timely.
研究产碳青霉烯酶阴沟肠杆菌(E.cloacae)的基因型及临床特征,为有效控制医院感染奠定基础。
收集2007年1月至2014年12月分离的阴沟肠杆菌。采用改良Hodge试验(MHT)和EDTA纸片协同试验筛选出对碳青霉烯类药物敏感性降低的菌株。通过PCR扩增检测blaKPC、blaIMP、blaVIM、blaOXA - 48和blaNDM - 1基因的基因型,PCR产物进行测序并通过Blast(http://blast.ncbi.nlm.nih.gov/Blast.cgi)分析。进行接合转移试验以证明阴沟肠杆菌产生的碳青霉烯酶基因的水平传播。同时,分析感染所选菌株患者的临床流行病学资料。
通过MHT、EDTA纸片协同试验和PCR扩增检测到64株产碳青霉烯酶阴沟肠杆菌。64株感染菌株中45株(70.3%)来自医院感染,19株(29.7%)来自社区感染。菌株主要从分泌物样本和痰液样本中分离得到,分别占65.6%(42/64)和23.4%(15/64)。主要临床科室为骨科(43.8%)、烧伤科(21.9%)、重症监护病房(18.8%)和儿科(14.1%)。更换床单、侵入性操作和留置导管是产碳青霉烯酶阴沟肠杆菌传播的危险因素,感染患者住院时间长、治愈率低,头孢菌素酶抑制剂复合制剂或碳青霉烯类药物使用频率高(均P<0.05)。64株菌株对除多粘菌素和替加环素外的大多数抗生素的最低抑菌浓度(MIC)升高。经Blast比对,64株菌株中29株为blaIMP - 4基因型,35株为blaIMP - 8基因型,未检测到blaVIM、blaOXA - 其48和blaNDM - 1基因型。接合转移试验结果显示受体菌株获得了碳青霉烯耐药性,且受体菌株耐药基因序列与供体菌株相同。
阴沟肠杆菌耐药性不断增加,IMP - 4和IMP - 8碳青霉烯酶是菌株产生的主要酶类。由于耐药基因可通过接合转移系统在菌株间水平传播,该菌株已在医院科室局部传播,因此及时控制传播危险因素很重要。